Journal of Advanced Biomedical Sciences
JABS
Sun, Dec 22, 2024
[Archive]
Volume 14, Issue 1 (1-2024)
JABS 2024, 14(1): 21-26 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Armand N, Morovvati H, Azizi Y. The Effect of Silver Nanoparticles Produced from Extract of Medicinal Plant (Kelussia) on Kidney Function Tests. JABS 2024; 14 (1) :21-26
URL: http://jabs.fums.ac.ir/article-1-2318-en.html
URL: http://jabs.fums.ac.ir/article-1-2318-en.html
1- Research Center for Herbal Medicine and Complementary Medicine, Alborz University of Medical Sciences, Karaj, Iran
2- Department of Basic Science, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran ,hmorovati@ut.ac.ir
3- Physiology Research Center, Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
2- Department of Basic Science, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran ,
3- Physiology Research Center, Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Abstract: (1069 Views)
Background & Objectives: Kelussia odoratissima is involved in the treatment of kidney stones, irritation of the urinary tract and kidney and bladder cleansing. It is useful for gout patients and is used to treat kidney and ureteral stones. The aim of this study was to investigate the effect of Kelussia odoratissima on renal function tests in male rats.
Materials & Methods: In this study, 20 rats were randomly divided into one control group and three treatment groups (n=5 per group). The treatment groups received a 40, 80, and 120 mg/kg silver nanoparticles produced by the extracts of Kelussia, orally once a day for 6 days. After taking a blood sample, a kidney function test was performed. SPSS software version 21 was used for data collection, and the results were presented as mean and standard deviation (mean±SEM).
Results: Oral administration of silver nanoparticles produced by Kelussia extracts at 80 mg/kg dose significantly reduced bilirubin and urea compared to the control group (P<0.05). The 120 mg/kg dose also significantly reduced urea compared to the control group (P<0.05). There was no significant effect on total protein, albumin and urea.
Conclusion: Silver nanoparticles produced by the Kelussia extracts did not show any negative effect on kidney function, but had some positive effect on waste removal.
Materials & Methods: In this study, 20 rats were randomly divided into one control group and three treatment groups (n=5 per group). The treatment groups received a 40, 80, and 120 mg/kg silver nanoparticles produced by the extracts of Kelussia, orally once a day for 6 days. After taking a blood sample, a kidney function test was performed. SPSS software version 21 was used for data collection, and the results were presented as mean and standard deviation (mean±SEM).
Results: Oral administration of silver nanoparticles produced by Kelussia extracts at 80 mg/kg dose significantly reduced bilirubin and urea compared to the control group (P<0.05). The 120 mg/kg dose also significantly reduced urea compared to the control group (P<0.05). There was no significant effect on total protein, albumin and urea.
Conclusion: Silver nanoparticles produced by the Kelussia extracts did not show any negative effect on kidney function, but had some positive effect on waste removal.
Type of Study: Research |
Subject:
Pharmaceutical Plants
Received: 2020/05/8 | Accepted: 2021/11/21 | Published: 2024/05/11
Received: 2020/05/8 | Accepted: 2021/11/21 | Published: 2024/05/11
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)